AUTISM SPECTRUM DISORDERS (ASDs) are a set of complex neurodevelopmental disorders defined behaviorally by impaired social interaction, delayed and disordered language, repetitive or stereotypic behavior, & restricted range of interests.
.
.
How can medical cannabis help a complex problem like autism? The key seems to be our Endocannabinoid System - the master regulatory system in our body. Recent research implicates the endocannabinoid deficiencies and a dysregulated endocannabinoid system in the diagnosis and potential treatment of autism.
.
.
The ECS represents a network of lipid signaling pathways. Regulating many, or all, that are dysregulated in ASD, positive for helping core symptoms. Improvements are a result of the medicinal effects of cannabis on the underlying medical conditions of autism.
.
.
Recent research from Stanford University shows that there is a documented deficiency of lower plasma levels of anandamide in individuals with ASD. Anandamide is the endocannabinoid that mimics THC in the body and plays a crucial role in memory, learning, social functioning, easing anxiety and much more.
.
.
With the vital role of the ECS system, along with the documented deficit of anandamide in those diagnosed, it seems entirely feasible that cannabinoid-rich extracts from whole plant cannabis can be utilized as useful agents for not just treating, but mapping the pathology of ASD. Along with many of the debilitating symptoms associated with. Families & physicians should have the authorized right to explore these options without fear of legal repercussions, despite age or severity of Autism Spectrum diagnosis.
.
.
Seventeen states plus the territory of Puerto Rico, recognize #AUTISM as a #qualifyingcondition for medical cannabis, including pediatric use. An additional seven states recognize #autismspectrumdisorder as a debilitating condition, and allow access with a doctors recommendation.
When will our #ASD individuals and their quality of life become a priority in #ohio ?

@ Bryan, Ohio